SCHEMBL21532697

SCHEMBL21532697

c1ccc(-c2nnc(-c3ccccc3)n2-c2cccc3c4ccccc4n(-c4cccc(-n5c6ccccc6c6ccc7oc8ccccc8c7c65)c4)c23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HIF1A Q16665 1/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 2/20 0.33
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 3/20 0.32
HSD17B10 Q99714 3/20 0.32
TSHR P16473 2/20 0.32
AVPR1A P37288 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CA12 O43570 2/20 0.32
CA9 Q16790 2/20 0.32
AKT1 P31749 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
POLB P06746 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532566 0.97 OPRD1 (0.34) OPRD1SMN1; SMN2MEN1KMT2AHIF1A
SCHEMBL21532791 0.93 AKT1 (0.33) OPRD1SMN1; SMN2MEN1KMT2AHIF1A
SCHEMBL21532714 0.93 OPRD1 (0.33) OPRD1SMN1; SMN2MEN1KMT2AHIF1A
SCHEMBL21532611 0.91 OPRD1 (0.33) OPRD1SMN1; SMN2MEN1KMT2AHIF1A
SCHEMBL21532702 0.90 ALDH1A1 (0.36) OPRD1SMN1; SMN2MEN1KMT2AGAA
SCHEMBL21532780 0.89 AKT1 (0.38) SMN1; SMN2HIF1AALDH1A1KDM4EHSD17B10
SCHEMBL21532699 0.89 KDM4E (0.37) OPRD1SMN1; SMN2MEN1KMT2AGAA
SCHEMBL21532694 0.89 ALDH1A1 (0.36) OPRD1SMN1; SMN2MEN1KMT2AGAA
SCHEMBL21532711 0.89 ALDH1A1 (0.36) OPRD1SMN1; SMN2MEN1KMT2AGAA
SCHEMBL21532713 0.88 OPRD1 (0.34) OPRD1SMN1; SMN2MEN1KMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 OPRD1 417/4885SMN1; SMN2 2430/4885MEN1 55/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 OPRD1 463/4885SMN1; SMN2 2103/4885MEN1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.